Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Taiwan
/
Pharmaceuticals & Biotech
Create a narrative
Lotus Pharmaceutical
TWSE:1795 Community
1
Narratives
written by author
0
Comments
on narratives written by author
2
Fair Values set
on narratives written by author
Create a narrative
Lotus Pharmaceutical
Popular
Undervalued
Overvalued
Lotus Pharmaceutical
AN
Analyst Price Target
Consensus Narrative from 5 Analysts
Alpha Choay Acquisition And New R&D Center Will Strengthen Southeast Asia Presence
Key Takeaways Strategic acquisitions and alliances are bolstering Lotus Pharmaceutical's growth and diversification, particularly in Southeast Asia. In-house production and a strong product pipeline are enhancing profitability and driving revenue and earnings growth.
View narrative
NT$371.80
FV
32.2% undervalued
intrinsic discount
7.03%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
Updated
narrative
Your Valuation for
1795
Lotus Pharmaceutical
Your Fair Value
NT$
Current Price
NT$252.00
6.1% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-442m
26b
2015
2018
2021
2024
2025
2027
2030
Revenue NT$25.9b
Earnings NT$7.1b
Advanced
Set as Fair Value